DANIELLE WISELEY: Open Payments
NPI 1912379421 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 49 payments from 13 companies in 2025. Trend: 2023 $2,730 · 2024 $1,853 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $438 |
| Arcutis Biotherapeutics, Inc. | 6 | $107 |
| UCB, Inc. | 3 | $82 |
| GENZYME CORPORATION | 2 | $73 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
| Galderma Laboratories, L.P. | 3 | $50 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $47 |
| Almirall LLC | 1 | $39 |
| Amgen Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
Products named: BOTOX, RINVOQ, SKYRIZI, Zoryve, Bimzelx, DUPIXENT, Sotyktu, Seysara.
Industry payments across GA — which companies pay providers there.
